Xu, M., Weng, H., & Dooley, S. (2013). Serum dihydroxyacetone kinase peptide m/z 520.3 as predictor of disease severity in patients with compensated chronic hepatitis B. Journal of translational medicine, 11, .
Chicago-Zitierstil (17. Ausg.)Xu, Ming-Yi, Honglei Weng, und Steven Dooley. "Serum Dihydroxyacetone Kinase Peptide M/z 520.3 as Predictor of Disease Severity in Patients with Compensated Chronic Hepatitis B." Journal of Translational Medicine 11 (2013).
MLA-Zitierstil (9. Ausg.)Xu, Ming-Yi, et al. "Serum Dihydroxyacetone Kinase Peptide M/z 520.3 as Predictor of Disease Severity in Patients with Compensated Chronic Hepatitis B." Journal of Translational Medicine, vol. 11, 2013.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.